According to those findings, we theorised that the impaired expansion observed in mice harbouring Drd3-deficient CD8+ T-cells could be due, at least in part, to a reduced migration of these cells through the secondary lymphoid organs, where APC would present the tumour antigens. This evidence concerns the gene DRD3 and neoplasm.